Wanghao Chen
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Magnetic T7 Peptide&AS1411 Aptamer-Modified Microemulsion for Triple Glioma-Targeted Delivery of Shikonin and Docetaxel.
Journal: Journal of pharmaceutical sciences
Published: January 20, 2021
LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.
Journal: Journal of cellular and molecular medicine
Published: May 04, 2020
AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.
Journal: Journal of pharmaceutical sciences
Published: July 12, 2019
The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Journal: Oncotarget
Published: January 21, 2016
c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma.
Journal: Brain : a journal of neurology
Published: May 01, 2015
MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells.
Journal: Journal of neuro-oncology
Published: April 06, 2014
MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
Journal: Journal of neuro-oncology
Published: February 28, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026